|
Volumn 277, Issue 9, 2002, Pages 6888-6897
|
Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMBINATION THERAPY;
CELLS;
CHEMOTHERAPY;
ORGANIC ACIDS;
PROTEINS;
BIOCHEMISTRY;
ADVANCED GLYCATION END PRODUCT;
AMPHOTERICIN;
RETINOIC ACID;
ANIMAL CELL;
ARTICLE;
CANCER CHEMOTHERAPY;
CELL DIFFERENTIATION;
CELL SURVIVAL;
CONTROLLED STUDY;
DRUG MECHANISM;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
MOUSE;
NERVE CELL DIFFERENTIATION;
NERVE FIBER GROWTH;
NEUROBLASTOMA;
NEUROBLASTOMA CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FAMILY;
RECEPTOR INTRINSIC ACTIVITY;
ANIMALS;
BLOTTING, WESTERN;
CELL DIFFERENTIATION;
CELL LINE;
CELL SURVIVAL;
CLONING, MOLECULAR;
COLORING AGENTS;
DNA FRAGMENTATION;
DNA, COMPLEMENTARY;
ELECTROPHORESIS, AGAR GEL;
GENES, DOMINANT;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HMGB1 PROTEIN;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MICE;
NEUROBLASTOMA;
NEURONS;
OLIGONUCLEOTIDES, ANTISENSE;
PLASMIDS;
RECEPTORS, IMMUNOLOGIC;
TETRAZOLIUM SALTS;
THIAZOLES;
TIME FACTORS;
TRANSFECTION;
TRETINOIN;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
EID: 0036510623
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M107627200 Document Type: Article |
Times cited : (48)
|
References (42)
|